Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $24.3300 (-3.83%) ($24.2600 - $25.2500) on Tue. Jul. 16, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.47% (three month average) | RSI | 62 | Latest Price | $24.3300(-3.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(60%) IWO(58%) XBI(58%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -1.735% in a week (0% probabilities). VIXM(-32%) VXX(-17%) UUP(-6%) TLT(-4%) IFRA(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.735% (StdDev 3.47%) | Hourly BBV | 0 () | Intraday Trend | -3.6% | | | |
|
5 Day Moving Average | $24.84(-2.05%) | 10 Day Moving Average | $24.54(-0.86%) | 20 Day Moving Average | $23.83(2.1%) | To recent high | -12.4% | To recent low | 18.8% | Market Cap | $1.511b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |